1MDN
WILD TYPE MYOGLOBIN WITH CO
X-RAY DIFFRACTION
Crystallization
Crystalization Experiments | ||||
---|---|---|---|---|
ID | Method | pH | Temperature | Details |
1 | 7.1 | 0.1 PHOSPHATE BUFFER PH 7.1 10 MG/ML PROTEIN |
Crystal Properties | |
---|---|
Matthews coefficient | Solvent content |
3.46 | 64.42 |
Crystal Data
Unit Cell | |
---|---|
Length ( Å ) | Angle ( ˚ ) |
a = 122 | α = 90 |
b = 42.17 | β = 92.73 |
c = 91.5 | γ = 90 |
Symmetry | |
---|---|
Space Group | I 1 21 1 |
Diffraction
Diffraction Experiment | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID # | Crystal ID | Scattering Type | Data Collection Temperature | Detector | Detector Type | Details | Collection Date | Monochromator | Protocol | |||||
1 | 1 | x-ray | 150 | IMAGE PLATE | RIGAKU RAXIS | M | SINGLE WAVELENGTH |
Radiation Source | |||||
---|---|---|---|---|---|
ID # | Source | Type | Wavelength List | Synchrotron Site | Beamline |
1 | ROTATING ANODE | RIGAKU RU200 |
Data Collection
Overall | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID # | Resolution (High) | Resolution (Low) | Percent Possible (Observed) | R Merge I (Observed) | R Sym I (Observed) | Net I Over Average Sigma (I) | Redundancy | Number Reflections (All) | Number Reflections (Observed) | Observed Criterion Sigma (F) | Observed Criterion Sigma (I) | B (Isotropic) From Wilson Plot | |||||||
1 | 1.7 | 24 | 96 | 0.068 | 0.068 | 19.5 | 8 | 48028 | 26.82 |
Refinement
Statistics | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diffraction ID | Structure Solution Method | Cross Validation method | Resolution (High) | Resolution (Low) | Number Reflections (Observed) | Number Reflections (R-Free) | Percent Reflections (Observed) | R-Work (Depositor) | R-Free (Depositor) | R-Free Selection Details | Mean Isotropic B | ||||||||
X-RAY DIFFRACTION | OTHER | THROUGHOUT | 1.98 | 24 | 32221 | 1560 | 96 | 0.198 | 0.262 | RANDOM | 33.43 |
Temperature Factor Modeling | ||||||
---|---|---|---|---|---|---|
Anisotropic B[1][1] | Anisotropic B[1][3] | Anisotropic B[2][2] | Anisotropic B[3][3] | |||
5.589 | 2.481 | 1.157 | -6.68 |
RMS Deviations | |
---|---|
Key | Refinement Restraint Deviation |
p_transverse_tor | 40.9 |
p_staggered_tor | 17.1 |
p_scangle_it | 6.345 |
p_mcangle_it | 4.902 |
p_scbond_it | 4.439 |
p_mcbond_it | 3.835 |
p_planar_tor | 3.2 |
p_multtor_nbd | 0.319 |
p_singtor_nbd | 0.201 |
p_chiral_restr | 0.128 |
Non-Hydrogen Atoms Used in Refinement | |
---|---|
Non-Hydrogen Atoms | Number |
Protein Atoms | 2471 |
Nucleic Acid Atoms | |
Solvent Atoms | 449 |
Heterogen Atoms | 86 |
Software
Software | |
---|---|
Software Name | Purpose |
CCP4 | model building |
REFMAC | refinement |
DENZO | data reduction |
CCP4 | data scaling |
CCP4 | phasing |